CompletedNot Applicable

The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases

Russia116 participantsStarted 2020-06-24

Plain-language summary

Investigation of the influence of combined oral contraception on the development and progression of chronic venous diseases

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. The investigators consistently include patients who have been prescribed hormonal tablets for contraception, namely 1) COCs with bioidentical estrogen; 2) COCs with ethinyl estradiol 30mkg according to the scheme 21 + 7; 3) COCs with ethinyl estradiol 20mkg according to the scheme 21 + 7.
✓. Clinical class C0-1 according to CEAP;

Development and progression of chronic venous diseases

Timeframe: 1 year

NCT IDNCT04451746

SponsorClinic of Phlebology and Laser Surgery, Chelyabinsk, Russia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-23